CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND BIOVECTRA INC. May 4, 2008 CONFIDENTIAL TREATMENT REQUESTEDCGMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement • February 5th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 5th, 2009 Company Industry JurisdictionINFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND BIOVECTRA INC. May 4, 2008 CONFIDENTIAL TREATMENT REQUESTEDCGMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 4th, 2009 Company Industry JurisdictionINFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND BIOVECTRA INC. May 4, 2008 CONFIDENTIAL TREATMENT REQUESTEDCGMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement • November 25th, 2008 • Helix BioPharma Corp • Ontario
Contract Type FiledNovember 25th, 2008 Company JurisdictionINFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.